Search Results for " Tafamidis "
Tafamidis Related Products
Tafamidis is a medication used primarily in the treatment of transthyretin amyloid cardiomyopathy (ATTR-CM), a heart condition caused by the buildup of amyloid deposits in the heart tissue. It works by stabilizing transthyretin (TTR), a protein that can misfold and form amyloid fibrils in conditions like ATTR.
SynZeal is a leading innovator in pharmaceutical reference standards. We supply high-quality Reference Standards of Tafamidis, pharmacopeial and non-pharmacopeial Tafamidis impurities, metabolites, stable isotope products, and nitrosamines (N-NO products). Tafamidis impurities reference standards are useful in pharmaceutical research. They are useful in product development, ANDA and DMF filing, quality control (QC), method validation, and stability studies. It is also useful in the identification of unknown impurities and the assessment of genotoxic potential.
Tafamidis-related products are thoroughly characterized. Tafamidis products are supplied with detailed COA & analytical data meeting regulatory compliance. We can also provide EP/USP traceable standards based on your requirements. The supplied products are re-tested at regular intervals.